Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

Autor: M. Opdam, V. van der Noort, M. Kleijn, A. Glas, I. Mandjes, S. Kleiterp, F. S. Hilbers, D. T. Kruger, A. D. Bins, P. C. de Jong, P. P. J. B. M. Schiphorst, T. van Dalen, B. Flameling, R. C. Rietbroek, A. Beeker, S. M. van den Heiligenberg, S. D. Bakker, A. N. M. Wymenga, I. M. Oving, R. M. Bijlsma, P. J. van Diest, J. B. Vermorken, H. van Tinteren, S. C. Linn

Publikováno v: Breast cancer research and treatment, 194(2), 265-278. Springer New York
Breast cancer research and treatment
Breast Cancer Research and Treatment, 194(2), 265-278. Springer New York
Opdam, M, van der Noort, V, Kleijn, M, Glas, A, Mandjes, I, Kleiterp, S, Hilbers, F S, Kruger, D T, Bins, A D, de Jong, P C, Schiphorst, P P J B M, van Dalen, T, Flameling, B, Rietbroek, R C, Beeker, A, van den Heiligenberg, S M, Bakker, S D, Wymenga, A N M, Oving, I M, Bijlsma, R M, van Diest, P J, Vermorken, J B, van Tinteren, H & Linn, S C 2022, ' Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature ', Breast Cancer Research and Treatment, vol. 194, no. 2, pp. 265-278 . https://doi.org/10.1007/s10549-022-06618-z

Purpose Guidelines recommend endocrine treatment for estrogen receptor-positive (ER+) breast cancers for up to 10 years. Earlier data suggest that the 70-gene signature (MammaPrint) has potential to select patients that have an excellent survival wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff14e4330cdee35c7a55ca1f5f2e824
https://doi.org/10.1007/s10549-022-06618-z

Inhibitory effect of selected Indian honey on colon cancer cell growth by inducing apoptosis and targeting the β-catenin/Wnt pathway.

Autor: Das, Neeladrisingha, Ray, Neelanjana, Patil, Abhinandan R., Saini, Shashank Sagar, Waghmode, Bhairavnath, Ghosh, Chandrachur, Patil, Sunita B., Patil, Sandeep B., Mote, Chandrasekhar S., Saini, Surendra, Saraswat, B. L., Sircar, Debabrata, Roy, Partha

Publikováno v: Food & Function; 8/7/2022, Vol. 13 Issue 15, p8283-8303, 21p

Biomimetic Nanomedicine Coupled with Neoadjuvant Chemotherapy to Suppress Breast Cancer Metastasis via Tumor Microenvironment Remodeling.

Autor: Liu, Hai‐jun, Wang, Junfeng, Wang, Mingming, Wang, Yuzhen, Shi, Shanshan, Hu, Xiangxiang, Zhang, Quanguang, Fan, Daping, Xu, Peisheng

Publikováno v: Advanced Functional Materials; 6/16/2021, Vol. 31 Issue 25, p1-13, 13p

Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting

Autor: Niven Mehra, Iris Kloots, Michiel Vlaming, Shafak Aluwini, Els Dewulf, Daniela E. Oprea-Lager, Henk van der Poel, Herman Stoevelaar, Derya Yakar, Chris H. Bangma, Elise Bekers, Roderick van den Bergh, Andries M. Bergman, Franchette van den Berkmortel, Steve Boudewijns, Winand N.M. Dinjens, Jurgen Fütterer, Tom van der Hulle, Guido Jenster, Leonie I. Kroeze, Michel van Kruchten, Geert van Leenders, Pim J. van Leeuwen, Wendy W.J. de Leng, R. Jeroen A. van Moorselaar, Walter Noordzij, Rogier A. Oldenburg, Inge M. van Oort, Irma Oving, Jack A. Schalken, Ivo G. Schoots, Ed Schuuring, Robert J. Smeenk, Ben G.L. Vanneste, Erik Vegt, André N. Vis, Kim de Vries, Peter-Paul M. Willemse, Maurits Wondergem, Margreet Ausems

Publikováno v: European Urology Open Science, 49, 23-31. Elsevier BV
European Urology Open Science, 49, 23-31
European urology open science, 49, 23-31. Elsevier
European Urology Open Science, 49, 23-31. Elsevier
Mehra, N, Kloots, I, Vlaming, M, Aluwini, S, Dewulf, E, Oprea-Lager, D E, van der Poel, H, Stoevelaar, H, Yakar, D, Bangma, C H, Bekers, E, van den Bergh, R, Bergman, A M, van den Berkmortel, F, Boudewijns, S, Dinjens, W N M, F?tterer, J, van der Hulle, T, Jenster, G, Kroeze, L I, van Kruchten, M, van Leenders, G, van Leeuwen, P J, de Leng, W W J, van Moorselaar, R J A, Noordzij, W, Oldenburg, R A, van Oort, I M, Oving, I, Schalken, J A, Schoots, I G, Schuuring, E, Smeenk, R J, Vanneste, B G L, Vegt, E, Vis, A N, de Vries, K, Willemse, P-P M, Wondergem, M & Ausems, M 2023, ' Genetic Aspects and Molecular Testing in Prostate Cancer : A Report from a Dutch Multidisciplinary Consensus Meeting ', European Urology Open Science, vol. 49, pp. 23-31 . https://doi.org/10.1016/j.euros.2022.11.011
European Urology Open Science, 49, pp. 23-31

Contains fulltext : 291602.pdf (Publisher’s version ) (Open Access) BACKGROUND: Germline and tumour genetic testing in prostate cancer (PCa) is becoming more broadly accepted, but testing indications and clinical consequences for carriers in each d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d684a6ac8fee8272916063132b08ecd
https://research.vumc.nl/en/publications/35edcc2d-d3ad-4ede-a135-e0c222143a77

IEEE Visualization Cumulative Index.

Publikováno v: IEEE Visualization, 2003. VIS 2003; 2003, p623-634, 12p